F.E. Maly

428 total citations
9 papers, 371 citations indexed

About

F.E. Maly is a scholar working on Immunology, Molecular Biology and Neurology. According to data from OpenAlex, F.E. Maly has authored 9 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in F.E. Maly's work include Immune Response and Inflammation (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). F.E. Maly is often cited by papers focused on Immune Response and Inflammation (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). F.E. Maly collaborates with scholars based in Switzerland, Germany and United Kingdom. F.E. Maly's co-authors include Andrew R. Cross, A.L. de Weck, T.W. Jungi, J F Gauchat, Clemens A. Dahinden, Adrian Urwyler, Owen Jones, Michio Nakamura, C. E. Walker and Christoph Walker and has published in prestigious journals such as The Journal of Immunology, Biochemical and Biophysical Research Communications and British Journal of Haematology.

In The Last Decade

F.E. Maly

9 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F.E. Maly Switzerland 6 177 143 63 43 40 9 371
Kenneth Wong Canada 11 130 0.7× 260 1.8× 106 1.7× 27 0.6× 22 0.6× 28 441
Yvonne G. Newhouse United States 13 297 1.7× 195 1.4× 73 1.2× 19 0.4× 12 0.3× 24 555
Sue A. Bauldry United States 10 235 1.3× 316 2.2× 113 1.8× 41 1.0× 19 0.5× 11 527
Raya Dana Israel 8 349 2.0× 288 2.0× 232 3.7× 42 1.0× 12 0.3× 10 619
Sabine Mathieu Germany 11 130 0.7× 394 2.8× 48 0.8× 13 0.3× 11 0.3× 13 549
Cheung H. Kwong United States 7 363 2.1× 258 1.8× 195 3.1× 48 1.1× 8 0.2× 9 579
Samia Yazid United Kingdom 13 134 0.8× 205 1.4× 87 1.4× 31 0.7× 19 0.5× 15 367
Parker Cw Australia 9 79 0.4× 157 1.1× 62 1.0× 20 0.5× 6 0.1× 23 424
Björn Odlander Sweden 13 153 0.9× 127 0.9× 173 2.7× 40 0.9× 10 0.3× 18 482
Sahra Amel Belambri France 10 252 1.4× 173 1.2× 53 0.8× 22 0.5× 30 0.8× 14 455

Countries citing papers authored by F.E. Maly

Since Specialization
Citations

This map shows the geographic impact of F.E. Maly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.E. Maly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.E. Maly more than expected).

Fields of papers citing papers by F.E. Maly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.E. Maly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.E. Maly. The network helps show where F.E. Maly may publish in the future.

Co-authorship network of co-authors of F.E. Maly

This figure shows the co-authorship network connecting the top 25 collaborators of F.E. Maly. A scholar is included among the top collaborators of F.E. Maly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.E. Maly. F.E. Maly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Maly, F.E., et al.. (1991). Evidence that exposure to fibrinogen or to antibodies directed against Mac‐1 (CD11b/CD18; CR3) modulates human monocyte effector functions. British Journal of Haematology. 77(1). 16–24. 34 indexed citations
2.
Maly, F.E.. (1990). Review Article the B Lymphocyte: A Newly Recognized Source of Reactive Oxygen Species with Immunoregulatory Potential. Free Radical Research Communications. 8(3). 143–148. 36 indexed citations
3.
Jungi, T.W., et al.. (1990). Human monocytes CD36 and CD16 are signaling molecules. Evidence from studies using antibody-induced chemiluminescence as a tool to probe signal transduction.. PubMed. 71(1). 29–37. 59 indexed citations
4.
Weck, Anja, et al.. (1990). Long-lasting polymorphonuclear leukocyte oxidative burst activation by products of lipopolysaccharide-treated mononuclear cells is only partially due to tumor necrosis factor.. PubMed. 9(2). 187–97. 2 indexed citations
5.
Jungi, T.W., et al.. (1989). Low-affinity interaction of fibrinogen carboxy-gamma terminus with human monocytes induces an oxidative burst and modulates effector functions. Biochemical and Biophysical Research Communications. 165(1). 7–13. 17 indexed citations
6.
Maly, F.E., Michio Nakamura, J F Gauchat, et al.. (1989). Superoxide-dependent nitroblue tetrazolium reduction and expression of cytochrome b-245 components by human tonsillar B lymphocytes and B cell lines.. The Journal of Immunology. 142(4). 1260–1267. 123 indexed citations
7.
Maly, F.E., Andrew R. Cross, Owen Jones, et al.. (1988). The superoxide generating system of B cell lines. Structural homology with the phagocytic oxidase and triggering via surface Ig.. The Journal of Immunology. 140(7). 2334–2339. 92 indexed citations
8.
Maly, F.E., et al.. (1985). Dissociation of Natural Killing and Luminol-dependent Chemiluminescence. Immunobiology. 169(2). 162–174. 5 indexed citations
9.
Hinkkanen, Ari, F.E. Maly, & K. Decker. (1983). Quantitation of Immunoadsorbed Flavoprotein Oxidases by Luminol-Mediated Chemiluminescence. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 364(1). 407–412. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026